Genomic Mechanisms Influencing Outcome in Chronic Myeloid Leukemia

SIMPLE SUMMARY: Chronic myeloid leukemia (CML) is a blood cancer currently well managed with drugs that inhibit the protein responsible for the disease. However, some patients are resistant to these drugs and can progress to fatal phases of CML. This review focuses explicitly on genomic mechanisms t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Adelina, Shanmuganathan, Naranie, Branford, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833554/
https://www.ncbi.nlm.nih.gov/pubmed/35158889
http://dx.doi.org/10.3390/cancers14030620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833554/
https://www.ncbi.nlm.nih.gov/pubmed/35158889
http://dx.doi.org/10.3390/cancers14030620

Ejemplares similares